Debora Gagliato

6PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 06, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).

Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo

|Jul 20, 2022
Association Between GATA3 and Histopathological and Immunohistochemical Parameters in Early-Infiltrating Breast Carcinomas.

Priscila de Medeiros Souza, Filomena Marino Carvalho, Fernando N Aguiar

|Sep 05, 2020
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge.

Debora de Melo Gagliato, Antonio C Buzaid, Jose Manuel Perez-Garcia

|May 21, 2020
Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer.

Debora de Melo Gagliato, Xiudong Lei, Sharon H Giordano

|Mar 15, 2016
An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report.

Debora de Melo Gagliato, Rudinei Diogo Marques Linck, Regis Otaviano Franca Bezerra

Pageof 1